Purek Holdings Corp. Announces Commencement of Trading on the TSX Venture Exchange
PHOENIX, Dec. 11, 2020 (GLOBE NEWSWIRE) -- PureK Holdings Corp. (the "Company") (TSX Venture: PKAN), formerly AF1 Capital Corp., is...
PHOENIX, Dec. 11, 2020 (GLOBE NEWSWIRE) -- PureK Holdings Corp. (the "Company") (TSX Venture: PKAN), formerly AF1 Capital Corp., is...
– Immune Stimulation Augmented by +1,300% at 6-months Post-NPS Treatment – – Statistically Significant Difference of Duration of Immune Response...
New data accrued from 19 PNH patients treated for over 30 cumulative patient-years show that self-administered nomacopan is well-tolerated and...
Pivotal Phase III study in patients with severe dermatological condition bullous pemphigoid (BP) planned to start H1 2021 following successful...
DENVER, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider...
Soleno intends to submit plans to FDA to conduct further analyses of clinical data from completed and ongoing studies of...
CHMP recommends approval of Plavix® (clopidogrel) with aspirin in adults for certain types of strokes CHMP issues positive opinion for...
Successfully completed listing on US Nasdaq and raised over $150 million during recent IPO and preceding crossover round Funds to...
BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company aimed at developing and commercializing therapies...
Please read the full announcement in PDF Attachment 2020_64_New_segment_reporting
MISSISSAUGA, Ontario, Dec. 11, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce...
NORCROSS, Ga., Dec. 11, 2020 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins,...
Company announcement – No. 59 / 2020 Copenhagen, December 11, 2020 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20...
THE WOODLANDS, Texas, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it had entered...
MONTREAL, Dec. 11, 2020 (GLOBE NEWSWIRE) -- ExCellThera Inc., a clinical-stage molecular medicine company delivering molecules and bioengineering solutions to...
Jordana Bernard, MBA, FATA innovaTel Telepsychiatry Hires New Chief Compliance Officer ERIE, Pa., Dec. 11, 2020 (GLOBE NEWSWIRE) -- innovaTel...
MELBOURNE, Australia, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology...
Sale Marks Milestone for Company's Commercial expansion at leading Center of ExcellenceWestport, CT, Dec. 11, 2020 (GLOBE NEWSWIRE) -- BioSig...
CAMBRIDGE, Mass., Dec. 11, 2020 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing...
THE WOODLANDS, Texas, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that it has received...